Dr. Richard Wenzel is a principal in the Life Sciences Practice at CRA’s Munich office with more than four years of consulting experience. He specializes in strategy and launch preparation of innovative therapies and devices, developing fact-based commercial and business models with measurable revenue impact.
Dr. Wenzel works on international projects delivering implementable results on (portfolio) strategy, global market access, and reimbursement. He offers a diverse background in pricing analytics and commercialization.
Prior to joining CRA, he worked as a senior consultant for the Simon-Kucher life sciences division in Germany and the US.